AAAAAA

   
Results: 1-9 |
Results: 9
Phase I trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer
Authors: Rudin, CM Holmlund, J Fleming, GF Mani, S Stadler, WM Schumm, P Monia, BP Johnston, JF Geary, R Yu, RZ Kwoh, TJ Dorr, FA Ratain, MJ
Citation: Cm. Rudin et al., Phase I trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer, CLIN CANC R, 7(5), 2001, pp. 1214-1220
Transcriptional activation of short interspersed elements by DNA-damaging agents
Authors: Rudin, CM Thompson, CB
Citation: Cm. Rudin et Cb. Thompson, Transcriptional activation of short interspersed elements by DNA-damaging agents, GENE CHROM, 30(1), 2001, pp. 64-71
A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest
Authors: George, CM Haraf, DJ Mauer, AM Krauss, SA Hoffman, PC Rudin, CM Szeto, L Vokes, EE
Citation: Cm. George et al., A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest, INV NEW DR, 19(4), 2001, pp. 303-310
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer
Authors: Vokes, EE Gordon, GS Rudin, CM Mauer, AM Watson, S Krauss, S Arrieta, R Golomb, HM Hoffman, PC
Citation: Ee. Vokes et al., A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer, INV NEW DR, 19(4), 2001, pp. 329-333
Cell line dependence of Bcl-2-induced alteration of glutathione handling
Authors: Schor, NF Rudin, CM Hartman, AR Thompson, CB Tyurina, YY Kagan, VE
Citation: Nf. Schor et al., Cell line dependence of Bcl-2-induced alteration of glutathione handling, ONCOGENE, 19(3), 2000, pp. 472-476
What keeps a resting T cell alive?
Authors: Thompson, CB Rathmell, JC Frauwirth, KA Lindsten, T Rudin, CM Opferman, JT Ashton-Rickardt, PG Harris, MH Chandel, NS Schumacker, PT Vander Heiden, MG
Citation: Cb. Thompson et al., What keeps a resting T cell alive?, COLD S HARB, 64, 1999, pp. 383-387
Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-x(L) overexpression do not prevent early mitochondrial events but still depress caspase activity
Authors: Carthy, CM Granville, DJ Jiang, HJ Levy, JG Rudin, CM Thompson, CB McManus, BM Hunt, DWC
Citation: Cm. Carthy et al., Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-x(L) overexpression do not prevent early mitochondrial events but still depress caspase activity, LAB INV, 79(8), 1999, pp. 953-965
Bcl-x(L) and Bcl-2 expression in squamous cell carcinoma of the head and neck
Authors: Pena, JC Thompson, CB Recant, W Vokes, EE Rudin, CM
Citation: Jc. Pena et al., Bcl-x(L) and Bcl-2 expression in squamous cell carcinoma of the head and neck, CANCER, 85(1), 1999, pp. 164-170
Signal transduction pathways that regulate cell survival and cell death
Authors: Dragovich, T Rudin, CM Thompson, CB
Citation: T. Dragovich et al., Signal transduction pathways that regulate cell survival and cell death, ONCOGENE, 17(25), 1998, pp. 3207-3213
Risultati: 1-9 |